Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maqui Berry Extract for Oral Candidiasis
NCT05916729Phase 4Unknown
- Sponsor
- University of Belgrade
- Start
- May 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial (6 arms), sponsored by University of Belgrade. Primary endpoints: Presence of Candida albicans after therapy at first reexamination at 1.5 years, Presence of Candida albicans after therapy at second reexamination at 1.5 years and 2 more. Status: unknown.
Beyond the preview
Go deeper on NCT05916729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05916729.